Thomas Schulze

Thomas Schulze is a Senior Professor at Upstate Medical University, specializing in biological psychiatry and psychiatric genetics. His research focuses on the molecular mechanisms underlying severe mental disorders, including schizophrenia and bipolar disorder, with particular emphasis on transcriptomics, microRNA expression profiles, and pharmacogenetics. Recent work includes investigating immune cell contributions to lithium treatment response, the role of microRNAs in executive functions, and the implementation of responsible artificial intelligence frameworks in psychiatric guidelines. He has also conducted studies on trauma-related mental health outcomes among Kurdish survivors of chemical attacks and developed the PSY-PGx intervention for pharmacogenetics in psychiatry. His publications appear in leading journals such as Molecular Psychiatry and World Psychiatry.